AAAAAA

   
Results: 1-8 |
Results: 8

Authors: Wood, MD Reavill, C Trail, B Wilson, A Stean, T Kennett, GA Lightowler, S Blackburn, TP Thomas, D Gager, TL Riley, G Holland, V Bromidge, SM Forbes, IT Middlemiss, DN
Citation: Md. Wood et al., SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety, NEUROPHARM, 41(2), 2001, pp. 186-199

Authors: Bromidge, SM Dabbs, S Davies, S Duckworth, DM Forbes, IT Jones, GE Jones, J King, FD Saunders, DV Blackburn, TP Holland, V Kennett, GA Lightowler, S Middlemiss, DN Riley, GJ Trail, B Wood, MD
Citation: Sm. Bromidge et al., 1-[2-[(heteroaryloxy)heteroaryl]carbamoyl]indolines: Novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/anxiolyticagents, BIOORG MED, 10(16), 2000, pp. 1863-1866

Authors: Bromidge, SM Davies, S Duckworth, DM Forbes, IT Jones, GE Jones, J King, FD Blackburn, TP Holland, V Kennett, GA Lightowler, S Middlemiss, DN Riley, GJ Trail, B Wood, MD
Citation: Sm. Bromidge et al., 1-[2-[(heteroarylmethoxy)aryl]carbamoyl]indolines are selective and orallyactive 5-HT2C receptor inverse agonists, BIOORG MED, 10(16), 2000, pp. 1867-1870

Authors: Clapham, JC Arch, JRS Chapman, H Haynes, A Lister, C Moore, GBT Piercy, V Carter, SA Lehner, I Smith, SA Beeley, LJ Godden, RJ Herrity, N Skehel, M Changani, KK Hockings, PD Reid, DG Squires, SM Hatcher, J Trail, B Latcham, J Rastan, S Harper, AJ Cadenas, S Buckingham, JA Brand, MD Abuin, A
Citation: Jc. Clapham et al., Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean, NATURE, 406(6794), 2000, pp. 415-418

Authors: Reavill, C Taylor, SG Wood, MD Ashmeade, T Austin, NE Avenell, KY Boyfield, I Branch, CL Cilia, J Coldwell, MC Hadley, MS Hunter, AJ Jeffrey, P Jewitt, F Johnson, CN Jones, DNC Medhurst, AD Middlemiss, DN Nash, DJ Riley, GJ Routledge, C Stemp, G Thewlis, KM Trail, B Vong, AKK Hagan, JJ
Citation: C. Reavill et al., Pharmacological actions of a novel, high-affinity, and selective human dopamine D-3 receptor antagonist, SB-277011-A, J PHARM EXP, 294(3), 2000, pp. 1154-1165

Authors: Bromidge, SM Dabbs, S Davies, DT Davies, S Duckworth, DM Forbes, IT Gaster, LM Ham, P Jones, GE King, FD Mulholland, KR Saunders, DV Wyman, PA Blaney, FE Clarke, SE Blackburn, TP Holland, V Kennett, GA Lightowler, S Middlemiss, DN Trail, B Riley, GJ Wood, MD
Citation: Sm. Bromidge et al., Biarylcarbamoylindolines are novel and selective 5-HT2C receptor inverse agonists: Identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent, J MED CHEM, 43(6), 2000, pp. 1123-1134

Authors: Kennett, G Lightowler, S Trail, B Bright, F Bromidge, S
Citation: G. Kennett et al., Effects of RO 60 0175, a 5-HT2C receptor agonist, in three animal models of anxiety, EUR J PHARM, 387(2), 2000, pp. 197-204

Authors: Kennett, GA Trail, B Bright, F
Citation: Ga. Kennett et al., Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated, NEUROPHARM, 37(12), 1998, pp. 1603-1610
Risultati: 1-8 |